Outset Medical, Inc.
OM
$4.62
-$0.07-1.49%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.01% | 5.09% | 4.65% | 2.47% | -7.84% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.01% | 5.09% | 4.65% | 2.47% | -7.84% |
| Cost of Revenue | -5.43% | -2.74% | -5.10% | -8.86% | -21.36% |
| Gross Profit | 15.24% | 20.13% | 26.01% | 30.77% | 32.80% |
| SG&A Expenses | -8.60% | -17.31% | -22.48% | -26.38% | -23.90% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -10.60% | -16.40% | -20.37% | -24.70% | -26.90% |
| Operating Income | 26.49% | 38.81% | 43.64% | 46.51% | 42.01% |
| Income Before Tax | 34.70% | 36.51% | 37.87% | 38.55% | 32.63% |
| Income Tax Expenses | 84.68% | 46.23% | 1.98% | -22.31% | -9.94% |
| Earnings from Continuing Operations | 34.24% | 36.20% | 37.70% | 38.50% | 32.56% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 34.24% | 36.20% | 37.70% | 38.50% | 32.56% |
| EBIT | 26.49% | 38.81% | 43.64% | 46.51% | 42.01% |
| EBITDA | 26.21% | 39.62% | 45.02% | 48.03% | 43.42% |
| EPS Basic | 85.57% | 81.63% | 68.50% | 57.53% | 42.89% |
| Normalized Basic EPS | 84.89% | 84.11% | 70.95% | 59.31% | 44.09% |
| EPS Diluted | 85.57% | 81.63% | 68.50% | 57.53% | 42.89% |
| Normalized Diluted EPS | 84.89% | 84.11% | 70.95% | 59.31% | 44.09% |
| Average Basic Shares Outstanding | 309.90% | 335.93% | 236.71% | 134.91% | 31.21% |
| Average Diluted Shares Outstanding | 309.90% | 335.93% | 236.71% | 134.91% | 31.21% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |